Close Menu

NEW YORK (GenomeWeb) — Precipio said today that it anticipates a 140 percent jump in its third quarter revenues amid strong performance by its core pathology services business.

For the three-month period ended Sept. 30, New Haven, Connecticut-based Precipio posted preliminary revenues of $648,000 compared to $270,000 in the same period a year earlier. Driving the increase was continued volume growth in the firm's pathology services unit.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.